Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HiLo: High vs Low Dose Radioiodine with or without rhTSH in Thyroid Cancer
NCT00415233Phase 3Unknown
- Sponsor
- University College London
- Start
- Nov 2006
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thyrotropin alfa, iodine-131 in differentiated thyroid cancer (DTC), sponsored by University College London. Status: unknown.
02
Drugs
thyrotropin alfaiodine-131
03
Conditions
differentiated thyroid cancer (DTC)
Beyond the preview
Go deeper on NCT00415233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00415233.